Intraoperative fresh-frozen plasma versus human albumin in craniofacial surgery − A pilot study comparing coagulation profiles in infants younger than 12 months

Summary

The transfusion of fresh-frozen plasma (FFP) is suggested to minimize dilution coagulopathy when applied instead of colloids during paediatric craniofacial surgery (pCFS). We prospectively compared plasmatic haemostaseologic function between volume replacement with FFPs versus human albumin (HA) in a pilot study. Thirty infants with primary craniosynostosis were scheduled for pCFS. In 15 of those, FFPs were available from the identical donor as for packed red blood cells (pRBC), and were thus employed for intraoperative volume replacement. The remaining 15 infants were infused with HA-5% instead. Haemoglobin (Hb)-values, global coagulation parameters (activated partial thromboplastin time-aPTT; prothrombin time-PT), selected clotting factors (F) (VIII, XI, XIII), antithrombin-AT, fibrinolytic factors (fibrinogen; plasminogen; alpha2-antiplasmin-α2A), and activation parameters (thrombin-antithrombin-complex-TAT; plasmin-antiplasmin-complex-PAP; D-dimers) were assessed and compared between both groups after induction of anaesthesia, before transfusion of pRBC, and at the end of surgery. Patients and treatment characteristics were balanced between both groups. Prolongation of aPTT and decreases of PT, FXI, FXIII, AT3, and fibrinolytic factors were more pronounced in the HA-group. Increases in F VIII activity, activation parameters, and the course of Hb-values were similar among both groups. There was no difference regarding clinical endpoints (peri-/postoperative pRBC-transfusions, postoperative blood loss). In conclusion, the application of HA was associated with a more distinct dilution of procoagulant factors, AT3, and fibrinolytic factors than the use of FFPs. However, the course of activation markers suggested a similar extent of clotting and fibrinolytic activation with the use of both transfusion regimens, and there were no differences with regard to clinical endpoints.

Keywords

Craniosynostosis - perioperative care - red blood cell transfusion - blood coagulation factors - fibrinolysis - blood coagulation disorders

• References

• 1 Kabbani H, Raghuveer TS. Craniosynostosis. Am Fam Physician 2004; 69: 2863-2870.
• 2 McCarthy JG, Glasberg SB, Cutting CB. et al. Twenty-year experience with early surgery for craniosynostosis: I. Isolated craniofacial synostosis--results and unsolved problems. Plast Reconstr Surg 1995; 96: 272-283.
• 3 Panchal J, Uttchin V. Management of craniosynostosis. Plast Reconstr Surg 2003; 111: 2032-2048 quiz49.
• 4 Williams JK, Ellenbogen RG, Gruss JS. State of the art in craniofacial surgery: nonsyndromic craniosynostosis. Cleft Palate Craniofac J 1999; 36: 471-485.
• 5 Di Rocco C, Tamburrini G, Pietrini D. Blood sparing in craniosynostosis surgery. Semin Pediatr Neurol 2004; 11: 278-287.
• 6 Williams GD, Ellenbogen RG, Gruss JS. Abnormal coagulation during pediatric craniofacial surgery. Pediatr Neurosurg 2001; 35: 5-12.
• 7 Hobisch-Hagen P. Hemodilution and coagulation. An overview. Minerva Anestesiol 2002; 68: 178-181.
• 8 Ng KF, Lam CC, Chan LC. In vivo effect of haemodilution with saline on coagulation: a randomized controlled trial. Br J Anaesth 2002; 88: 475-480.
• 9 Ruttmann TG. Haemodilution enhances coagulation. Br J Anaesth 2002; 88: 470-472.
• 10 Ruttmann TG, James MF. Haemodilutionand coagulation: acaveat. Anasthesiol Intensivmed Notfallmed Schmerzther 2000; 35: 707-709.
• 11 Innerhofer P, Fries D, Klingler A. et al. In vivo effect of haemodilution with saline on coagulation. Br J Anaesth 2002; 89: 934 author reply-6.
• 12 Casbard AC, Williamson LM, Murphy MF. et al. The role of prophylactic fresh frozen plasma in decreasing blood loss and correcting coagulopathy in cardiac surgery. A systematic review. Anaesthesia 2004; 59: 550-558.
• 13 Oliver Jr WC, Beynen FM, Nuttall GA. et al. Blood loss in infants and children for open heart operations: albumin 5% versus fresh-frozen plasma in the prime. Ann Thorac Surg 2003; 75: 1506-1512.
• 14 Declerck PJ, Mombaerts P, Holvoet P. et al. Fibrinolytic response and fibrin fragment D-dimer levels in patients with deep vein thrombosis. Thromb Haemost 1987; 58: 1024-1029.
• 15 Clauss A. Rapid physiological coagulation method in determination of fibrinogen. Acta Haematol 1957; 17: 237-246.
• 16 Epstein NE. A review of the risks and benefits of differing prophylaxis regimens for the treatment of deep venous thrombosis and pulmonary embolismin neurosurgery. Surg Neurol 2005; 64: 295-301.
• 17 Swann KW, Black PM. Deep vein thrombosis and pulmonary emboli in neurosurgical patients: a review. J Neurosurg 1984; 61: 1055-1062.
• 18 Goobie SM, Soriano SG, Zurakowski D. et al. Hemostatic changes in pediatric neurosurgical patientsas evaluated by thrombelastograph. Anesth Analg 2001; 93: 887-892.